| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Bondronat | Roche | Roche Products | 6mg | 1 | Injection | per ampoule | KES 34,092.00 |
| Bondronat | Roche | Roche Products | 50mg | 28 | Tablet | per tablet | KES 43,689.00 |
| Bondronat | Roche | Roche Products | 50mg | 1 | Tablet | per tablet | KES 5,233.00 |
| Bonviva | Roche | Roche Products | 150mg | 1 | Tablet | per tablet | KES 5,730.00 |
| Bonviva | Roche | Roche Products | 150mg | 3 | Tablet | per tablet | KES 15,757.00 |
| Bonviva | Roche | Roche Products | 3mg | 1 | Injection | per ampoule | KES 15,757.00 |
| Cadronate | Meyer Organics | Galaxy Pharmaceuticals Ltd | 150mg | 1 | Tablet | per tablet | KES 3,600 |
| Ibandronic Acid More info | |
|---|---|
| Mode Of Action | Aminobisphosphonates act as specific inhibitors of osteoclast-mediated bone resorption. They bind to the hydroxyapatite in bones. |
| Drug Indication | Osteoporosis in postmenopausal women, prevention of osteoporosis in postmenopausal women and Paget's disease of bones |
| Precautions | Treatment of hypocalcemia and other bone and mineral metabolism first before starting on therapy; dysphagia, esophagitis and esophageal or gastric ulcers |
| Contra-Indications | Patients known to be hypersensitive (allergic) to ibandronic acid and other bisphosphonates |
| Side Effects | Headache; GI disturbances; abdominal pain; rash; myalgia; flu-like illness |
| Dosage | Orally: 50mg OD. Inf: 6 mg IV given every 3-4 weeks. The dose should be infused over 1 hr. |
| Pregnancy Category | Category B3 |
| Pregnancy Category Description | Drugs which have been taken by only a small number of pregnant women and women of child-bearing age with no any established rise in the frequency of malformations or other direct or indirect detrimental effects on the foetus having been noted. Studies in animals show evidence of an increased occurrence of foetal damage, the significance of which is uncertain in human |
| Drug Category | DRUGS AFFECTING NUTRITION AND METABOLISM |
| Drug Sub-Category | Bisphosphonates |